<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre=": Research Article HIV care continuum characteristics among people with" exact="opioid use disorder" post="and HIV in Vietnam: baseline results from the BRAVO"/>
 <result pre="Research Article HIV care continuum characteristics among people with opioid" exact="use disorder" post="and HIV in Vietnam: baseline results from the BRAVO"/>
 <result pre="characteristics that contribute to initiating antiretroviral therapy (ART) and achieving" exact="viral" post="suppression among HIV people with opioid use disorder in"/>
 <result pre="therapy (ART) and achieving viral suppression among HIV people with" exact="opioid use disorder" post="in Vietnam. The primary objective of this analysis was"/>
 <result pre="(ART) and achieving viral suppression among HIV people with opioid" exact="use disorder" post="in Vietnam. The primary objective of this analysis was"/>
 <result pre="among HIV people with opioid use disorder in Vietnam. The" exact="primary" post="objective of this analysis was to evaluate associations between"/>
 <result pre="in the HIV care continuum of ART initiation and HIV" exact="viral" post="suppression among people with opioid use disorder and HIV"/>
 <result pre="of ART initiation and HIV viral suppression among people with" exact="opioid use disorder" post="and HIV in Vietnam. Methods We assessed baseline participant"/>
 <result pre="ART initiation and HIV viral suppression among people with opioid" exact="use disorder" post="and HIV in Vietnam. Methods We assessed baseline participant"/>
 <result pre="Methods We assessed baseline participant characteristics, ART status, and HIV" exact="viral" post="suppression (HIV RNA PCRâ€‰ Results Among 283 study participants,"/>
 <result pre="increased likelihood of current prescription for ART at baseline. Greater" exact="depression" post="symptoms were negatively associated with receipt of ART (aORâ€‰=â€‰0.97,"/>
 <result pre="all included covariates, only receipt of ART was associated with" exact="viral" post="suppression (aORâ€‰=â€‰25.9, 95% CIâ€‰=â€‰(12.5, 53.8). In bivariate analyses, methamphetamine"/>
 <result pre="analyses, methamphetamine was negatively correlated with ART prescription (pâ€‰=â€‰0.07) and" exact="viral" post="suppression (pâ€‰=â€‰0.08). Conclusion While fewer than 90% of participants"/>
 <result pre="received ART, 90% of those on ART had achieved HIV" exact="viral" post="suppression at baseline, suggesting that interventions to improve uptake"/>
 <result pre="Vietnam. Social determinants of health associated with ART and HIV" exact="viral" post="suppression suggest that social support may be a key"/>
 <result pre="Keywords HIV care continuum Opioid use Vietnam Anti-retroviral medication HIV" exact="viral" post="suppression Funding http://dx.doi.org/10.13039/100000026National Institute on Drug Abuse UG1DA015815R01DA037441KorthuisP. Todd"/>
 <result pre="Funding http://dx.doi.org/10.13039/100006108National Center for Advancing Translational Sciences UL1TR002369 Background Opioid" exact="use disorder" post="(OUD) and human immunodeficiency virus (HIV) are intertwined epidemics"/>
 <result pre="Translational Sciences UL1TR002369 Background Opioid use disorder (OUD) and human" exact="immunodeficiency" post="virus (HIV) are intertwined epidemics worldwide; around one-third of"/>
 <result pre="are intertwined epidemics worldwide; around one-third of all new HIV" exact="infections" post="outside of sub-Saharan African occur among people who inject"/>
 <result pre="around one-third of all new HIV infections outside of sub-Saharan" exact="African" post="occur among people who inject drugs [1, 2]. In"/>
 <result pre="Vietnam, people who use drugs experience even higher rates of" exact="HIV infection," post="with an estimated 60% of new HIV cases occurring"/>
 <result pre="the HIV care continuum, including anti-retroviral therapy (ART) initiation and" exact="viral" post="suppression, among people with opioid use disorder and HIV."/>
 <result pre="anti-retroviral therapy (ART) initiation and viral suppression, among people with" exact="opioid use disorder" post="and HIV. In 2014, the Joint United Nations Program"/>
 <result pre="therapy (ART) initiation and viral suppression, among people with opioid" exact="use disorder" post="and HIV. In 2014, the Joint United Nations Program"/>
 <result pre="people with opioid use disorder and HIV. In 2014, the" exact="Joint" post="United Nations Program on HIV/AIDS released goals for HIV"/>
 <result pre="and HIV. In 2014, the Joint United Nations Program on" exact="HIV/AIDS" post="released goals for HIV engagement and treatment by 2020:"/>
 <result pre="in Vietnam, including the cost of treatment [5], care coordination," exact="chronic" post="disease management, and peer networks [6]. However, little is"/>
 <result pre="Vietnam, including the cost of treatment [5], care coordination, chronic" exact="disease" post="management, and peer networks [6]. However, little is known"/>
 <result pre="half of those on ART now receive locally-funded care (versus" exact="external" post="aid) [8]. Despite these gains, we extrapolate from these"/>
 <result pre="clinics to provide methadone maintenance therapy (MMT) to people with" exact="opioid use disorder" post="[10]. Following the success of initial MMT pilot demonstrations,"/>
 <result pre="to provide methadone maintenance therapy (MMT) to people with opioid" exact="use disorder" post="[10]. Following the success of initial MMT pilot demonstrations,"/>
 <result pre="50,000 people [10]. Over the past several years, changes in" exact="external" post="aid challenged Vietnam to identify how to continue to"/>
 <result pre="Vietnam to identify how to continue to provide HIV and" exact="opioid use disorder" post="care in communities. Research completed in 2016 found most"/>
 <result pre="to identify how to continue to provide HIV and opioid" exact="use disorder" post="care in communities. Research completed in 2016 found most"/>
 <result pre="time [11]. Further data suggested that addressing both HIV and" exact="opioid use disorder" post="treatment can enhance HIV outcomes and decrease behaviors that"/>
 <result pre="[11]. Further data suggested that addressing both HIV and opioid" exact="use disorder" post="treatment can enhance HIV outcomes and decrease behaviors that"/>
 <result pre="few studies have explored what individual characteristics may contribute to" exact="viral" post="suppression in Vietnam regardless of opioid use. Several studies"/>
 <result pre="comorbid substance use disorders can decrease the likelihood of HIV" exact="viral" post="suppression [15, 16], though the majority of this effect"/>
 <result pre="to ART and use of trimethoprim/sulfamethoxazole as predictors of HIV" exact="viral" post="suppression, while a history of tuberculosis was a risk"/>
 <result pre="as predictors of HIV viral suppression, while a history of" exact="tuberculosis" post="was a risk factor for non-suppression [7]. In another"/>
 <result pre="associated with suboptimal HIV virologic suppression in Vietnam [18]. The" exact="primary" post="objective of this analysis was to evaluate associations between"/>
 <result pre="in the HIV care continuum of ART initiation and HIV" exact="viral" post="suppression (HIV-1 RNA PCRâ€‰ Methods Study design and setting"/>
 <result pre="The BRAVO trial enrolled people with HIV and moderate-to-severe opiate" exact="use disorder" post="to receive either methadone maintenance therapy (MMT) or buprenorphine/naloxone"/>
 <result pre="were selected based on the high prevalence of untreated opiate" exact="use disorder" post="among newly engaging people with a history of intravenous"/>
 <result pre="administered in Vietnamese and adapted for appropriateness during previous research." exact="Blood" post="specimens for HIV viral load PCR were collected at"/>
 <result pre="adapted for appropriateness during previous research. Blood specimens for HIV" exact="viral" post="load PCR were collected at HIV clinics and sent"/>
 <result pre="HIV clinics and sent to the National Hospital for Tropical" exact="Diseases" post="in Hanoi, Vietnam for HIV-1 PCR testing using Abbott"/>
 <result pre="inclusion if they were HIV positive, had current moderate-to-severe DSM-V" exact="opioid use disorder" post="(OUD), a positive urine drug screen for opioids at"/>
 <result pre="if they were HIV positive, had current moderate-to-severe DSM-V opioid" exact="use disorder" post="(OUD), a positive urine drug screen for opioids at"/>
 <result pre="to enroll. Participants were ineligible if they had a known" exact="hypersensitivity" post="to buprenorphine or naloxone, an aspartate aminotransferase or alanine"/>
 <result pre="aspartate aminotransferase or alanine aminotransferase greater than five times the" exact="upper" post="limit of normal, were currently pregnant or breastfeeding, had"/>
 <result pre="ART at the time of study enrollment, and 2) HIV" exact="viral" post="suppression at time of enrollment, defined as HIV RNA"/>
 <result pre="lifetime number of arrests, years since HIV diagnosis, and the" exact="Depression" post="Anxiety Stress Scales (DASS) [25] scores for depression, anxiety"/>
 <result pre="the Depression Anxiety Stress Scales (DASS) [25] scores for depression," exact="anxiety" post="and stress symptoms, which has been validated for use"/>
 <result pre="has been validated for use in Vietnamese [26]. Data analysis" exact="Primary" post="analysis We assessed bivariate associations (t-tests, Pearsonâ€™s chi-squared tests,"/>
 <result pre="analysis We assessed bivariate associations (t-tests, Pearsonâ€™s chi-squared tests, and" exact="Fisher" post="exact tests) of participant characteristics and separately, ART initiation"/>
 <result pre="tests) of participant characteristics and separately, ART initiation and HIV" exact="viral" post="suppression. Potential covariates were selected based on a priori"/>
 <result pre="both age and gender, and replaced the three participants missing" exact="viral" post="load at baseline as non-suppressed. Sensitivity analysis After completing"/>
 <result pre="load at baseline as non-suppressed. Sensitivity analysis After completing our" exact="primary" post="analyses, we identified influential observations using Pregibonâ€™s Delta-Beta statistic"/>
 <result pre="of associations changed, we planned to report these results alongside" exact="primary" post="study results. Results Participant baseline characteristics are reported in"/>
 <result pre="and adjusted associations between baseline characteristics and ART prescription and" exact="viral" post="suppression among people with HIV and opioid use disorder"/>
 <result pre="ART prescription and viral suppression among people with HIV and" exact="opioid use disorder" post="in Vietnam, 2015â€&quot;2019 All participants(nÂ =â€‰283) Prescribed ARTnÂ =â€‰191/273"/>
 <result pre="prescription and viral suppression among people with HIV and opioid" exact="use disorder" post="in Vietnam, 2015â€&quot;2019 All participants(nÂ =â€‰283) Prescribed ARTnÂ =â€‰191/273"/>
 <result pre="(12.1) pâ€‰=â€‰0.69 5.7 (14.4) â€&quot; pâ€‰=â€‰0.57 5.7 (14.5) â€&quot; DASS" exact="Depression" post="Sub-score (SD) 6.1 (10.2) pâ€‰=â€‰0.02 5.1 (7.3) 0.97 (0.94,"/>
 <result pre="amphetamines Fig. 1 HIV care continuum among people with co-occurring" exact="opioid use disorder," post="2015 to 2019 In bivariate analyses, increased age, number"/>
 <result pre="Fig. 1 HIV care continuum among people with co-occurring opioid" exact="use disorder," post="2015 to 2019 In bivariate analyses, increased age, number"/>
 <result pre="while positive urine drug screen for methamphetamine/amphetamines and increased DASS" exact="depression" post="sub-scores were associated lack of ART at study entry."/>
 <result pre="06 rehabilitation, and being on ART were associated with HIV" exact="viral" post="suppression at study entry, while a positive methamphetamine/amphetamine urine"/>
 <result pre="screen, number of years since HIV diagnosis, and increased DASS" exact="depression" post="sub-score were associated with a lack of HIV viral"/>
 <result pre="DASS depression sub-score were associated with a lack of HIV" exact="viral" post="suppression at baseline (Table 1). After adjusting for covariates,"/>
 <result pre="odds of being on ART at baseline. A higher DASS" exact="depression" post="score was negatively associated with being on ART (aORâ€‰=â€‰0.97,"/>
 <result pre="on ART (aORâ€‰=â€‰0.97, 95% CI 0.94, 0.9963). In the HIV" exact="viral" post="suppression model, only current ART use remained associated with"/>
 <result pre="viral suppression model, only current ART use remained associated with" exact="viral" post="suppression (aORâ€‰=â€‰25.9, 95% CI 12.5, 53.8) after adjusting for"/>
 <result pre="progress toward achieving the UNAIDS goal of 90% with HIV" exact="viral" post="suppression in Vietnam hinges on increasing the proportion of"/>
 <result pre="receiving ART. Inclusion of ART receipt in models of HIV" exact="viral" post="suppression eclipsed the potential effect of other participants characteristics,"/>
 <result pre="identify ways to help support people with HIV and co-occurring" exact="opioid use disorder" post="in ways that work for these patients [11]. Our"/>
 <result pre="ways to help support people with HIV and co-occurring opioid" exact="use disorder" post="in ways that work for these patients [11]. Our"/>
 <result pre="suggests that once people are engaged in ART treatment, achieving" exact="viral" post="suppression is highly feasible. Interventions to improve ART treatment"/>
 <result pre="were associated with already being prescribed ART at baseline; increased" exact="depression" post="symptoms were negatively associated with being on ART. The"/>
 <result pre="that marriage may be positively associated with ART initiation. While" exact="depression" post="is associated with suboptimal ART adherence [31] [32], studies"/>
 <result pre="potential association with ART initiation, with several studies demonstrating an" exact="absence of" post="association [33â€&quot;37]. This association has not, to our knowledge,"/>
 <result pre="Authors working in China suggest that subpopulations of patients with" exact="depression" post="may have differing levels of ART initiation [36]; our"/>
 <result pre="ART initiation [36]; our study suggests that patients with increased" exact="depression" post="symptoms were less likely to have initiated ART at"/>
 <result pre="one-fifth of patients living with HIV who were sampled endorsed" exact="depression" post="symptoms [38]. Improved mental health care access and engagement"/>
 <result pre="study participants, the strong association between ART receipt and HIV" exact="viral" post="suppression eclipsed other important participant characteristics associated with HIV"/>
 <result pre="viral suppression eclipsed other important participant characteristics associated with HIV" exact="viral" post="suppression in bivariate analysis, yet suggests that increasing access"/>
 <result pre="target of greater than 90% is likely to achieve HIV" exact="viral" post="suppression in people who receives ART. This study finding"/>
 <result pre="health approaches that only support ART roll-out without attention to" exact="substance use disorder" post="treatment. Rather, it is essential to support ongoing opioid"/>
 <result pre="approaches that only support ART roll-out without attention to substance" exact="use disorder" post="treatment. Rather, it is essential to support ongoing opioid"/>
 <result pre="use disorder treatment. Rather, it is essential to support ongoing" exact="opioid use disorder" post="prevention and treatment interventions in order to reduce medical"/>
 <result pre="disorder treatment. Rather, it is essential to support ongoing opioid" exact="use disorder" post="prevention and treatment interventions in order to reduce medical"/>
 <result pre="reduce medical comorbidity and non-AIDS related deaths among people with" exact="opioid use disorder" post="who account for the majority of HIV infections in"/>
 <result pre="medical comorbidity and non-AIDS related deaths among people with opioid" exact="use disorder" post="who account for the majority of HIV infections in"/>
 <result pre="opioid use disorder who account for the majority of HIV" exact="infections" post="in Vietnam [3]. Further research regarding the potential role"/>
 <result pre="self-management practices in Vietnam may suggest ways to improve HIV" exact="viral" post="suppression among people who inject drugs in other countries."/>
 <result pre="marital status, and history of 06 rehabilitation were associated with" exact="viral" post="suppression; a positive methamphetamine/amphetamine urine drug screen, years since"/>
 <result pre="urine drug screen, years since HIV diagnosis, and increased DASS" exact="depression" post="sub-score were associated with decreased odds of HIV viral"/>
 <result pre="DASS depression sub-score were associated with decreased odds of HIV" exact="viral" post="suppression. Similarly to ART status, marriage here may reflect"/>
 <result pre="[39] and Russia [40] suggest that marriage was associated with" exact="viral" post="suppression in these communities; this may be because of"/>
 <result pre="have demonstrated the negative association between co-occurring methamphetamine use and" exact="viral" post="suppression [41â€&quot;44]. Our finding in bivariate analyses maps onto"/>
 <result pre="investigation in this potentially hard-to-reach population. Finally, higher rates of" exact="depression" post="have also been associated with decreased viral suppression [45,"/>
 <result pre="higher rates of depression have also been associated with decreased" exact="viral" post="suppression [45, 46]. Improved mental health care access and"/>
 <result pre="structural characteristics potentially associated with being on ART or HIV" exact="viral" post="suppression. The BRAVO intervention, however, is a structural intervention"/>
 <result pre="strides to meet UNAIDS goals for HIV treatment initiation and" exact="viral" post="suppression by 2020. Future research should identify additional patient-level"/>
 <result pre="with aspects of the HIV care continuum among people with" exact="opioid use disorder," post="including longitudinal interventions of integrated care models for treatment"/>
 <result pre="aspects of the HIV care continuum among people with opioid" exact="use disorder," post="including longitudinal interventions of integrated care models for treatment"/>
 <result pre="HIV and OUD. Abbreviations ART Anti-Retroviral Therapy OUD Opioid Use" exact="Disorder" post="UNAIDS The Joint United Nations Programme on HIV/AIDS HIV/AIDS"/>
 <result pre="Abbreviations ART Anti-Retroviral Therapy OUD Opioid Use Disorder UNAIDS The" exact="Joint" post="United Nations Programme on HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired"/>
 <result pre="Opioid Use Disorder UNAIDS The Joint United Nations Programme on" exact="HIV/AIDS" post="HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome DASS Depression"/>
 <result pre="Use Disorder UNAIDS The Joint United Nations Programme on HIV/AIDS" exact="HIV/AIDS" post="Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome DASS Depression Anxiety"/>
 <result pre="UNAIDS The Joint United Nations Programme on HIV/AIDS HIV/AIDS Human" exact="Immunodeficiency" post="Virus/Acquired Immune Deficiency Syndrome DASS Depression Anxiety Stress Score"/>
 <result pre="United Nations Programme on HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune" exact="Deficiency Syndrome" post="DASS Depression Anxiety Stress Score BRAVO Buprenorphine to Improve"/>
 <result pre="Nations Programme on HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency" exact="Syndrome" post="DASS Depression Anxiety Stress Score BRAVO Buprenorphine to Improve"/>
 <result pre="on HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome DASS" exact="Depression" post="Anxiety Stress Score BRAVO Buprenorphine to Improve HIV Care"/>
 <result pre="3.DECISION OF THE PRIME MINISTER approving the National Strategy on" exact="HIV/AIDS" post="prevention and control in Viet Nam till 2010 with"/>
 <result pre="care in VietnamBMC Health Serv Res20121248310.1186/1472-6963-12-48323272730 7.JordanMRet al.Correlates of HIV-1" exact="viral" post="suppression in a cohort of HIV-positive drug users receiving"/>
 <result pre="7.JordanMRet al.Correlates of HIV-1 viral suppression in a cohort of" exact="HIV-positive" post="drug users receiving antiretroviral therapy in Hanoi, VietnamInt J"/>
 <result pre="patterns associated with risk of non-adherence to antiretroviral therapy among" exact="HIV-positive" post="illicit drug users in a Canadian setting: a longitudinal"/>
 <result pre="NT, Dung N, Trung NV, Kinh NV, Oka S. Long-term" exact="viral" post="suppression and immune recovery during first-line antiretroviral therapy: a"/>
 <result pre="recovery during first-line antiretroviral therapy: a study of an HIV-infected" exact="adult" post="cohort in Hanoi, Vietnam. J Int AIDS Soc. 2017;20(4):e25030."/>
 <result pre="Int AIDS Soc. 2017;20(4):e25030. 10.1002/jia2.25030. 18.RangarajanSet al.Factors associated with HIV" exact="viral" post="load suppression on antiretroviral therapy in VietnamJ Virus Erad2016229410127482442"/>
 <result pre="antiretroviral therapy in VietnamJ Virus Erad2016229410127482442 19.Abott RealTime HIV 1" exact="Viral" post="Load Assay. [cited 2019 July 16]; Available from: https://www.molecular.abbott/us/en/products/infectious-disease/realtime-hiv-1-viral-load."/>
 <result pre="outcomes in a veterans affairs populationAddiction2016111111975198410.1111/add.1350527349855 21.BradleyKAet al.The AUDIT alcohol" exact="consumption" post="questions: reliability, validity, and responsiveness to change in older"/>
 <result pre="questions: reliability, validity, and responsiveness to change in older male" exact="primary" post="care patientsAlcohol Clin Exp Res1998228184218499835306 22.BushKet al.The AUDIT alcohol"/>
 <result pre="primary care patientsAlcohol Clin Exp Res1998228184218499835306 22.BushKet al.The AUDIT alcohol" exact="consumption" post="questions (AUDIT-C): an effective brief screening test for problem"/>
 <result pre="23.BradleyKAet al.AUDIT-C as a brief screen for alcohol misuse in" exact="primary" post="careAlcohol Clin Exp Res20073171208121710.1111/j.1530-0277.2007.00403.x17451397 24.KorthuisPTEdelmanEJSubstance use and the HIV"/>
 <result pre="advancesAddict Sci Clin Pract20181311310.1186/s13722-018-0114-429530080 25.Lovibond SH, L.P., Manual for the" exact="depression" post="anxiety stress scales. Vol. 2. 1995, Sydney: Psychology Foundation"/>
 <result pre="Sci Clin Pract20181311310.1186/s13722-018-0114-429530080 25.Lovibond SH, L.P., Manual for the depression" exact="anxiety" post="stress scales. Vol. 2. 1995, Sydney: Psychology Foundation of"/>
 <result pre="2. 1995, Sydney: Psychology Foundation of Australia. 26.TranTDTranTFisherJValidation of the" exact="depression" post="anxiety stress scales (DASS) 21 as a screening instrument"/>
 <result pre="1995, Sydney: Psychology Foundation of Australia. 26.TranTDTranTFisherJValidation of the depression" exact="anxiety" post="stress scales (DASS) 21 as a screening instrument for"/>
 <result pre="anxiety stress scales (DASS) 21 as a screening instrument for" exact="depression" post="and anxiety in a rural community-based cohort of northern"/>
 <result pre="scales (DASS) 21 as a screening instrument for depression and" exact="anxiety" post="in a rural community-based cohort of northern Vietnamese womenBMC"/>
 <result pre="Infect Dis20151557010.1186/s12879-015-1309-x26714889 30.PhillipsTKet al.Linkage to care, mobility and retention of" exact="HIV-positive" post="postpartum women in antiretroviral therapy services in South AfricaJ"/>
 <result pre="Dis20151557010.1186/s12879-015-1309-x26714889 30.PhillipsTKet al.Linkage to care, mobility and retention of HIV-positive" exact="postpartum" post="women in antiretroviral therapy services in South AfricaJ Int"/>
 <result pre="services in South AfricaJ Int AIDS Soc201821Suppl 4e2511410.1002/jia2.2511430027583 31.SpringerSAChenSAlticeFDepression and" exact="symptomatic" post="response among HIV-infected drug users enrolled in a randomized"/>
 <result pre="low-, middle- and high-income countries: a systematic review and meta-analysisCurr" exact="HIV/AIDS" post="Rep201411329130710.1007/s11904-014-0220-125038748 33.VellozaJet al.Depression and ART initiation among HIV Serodiscordant"/>
 <result pre="HIV-infected adults in Johannesburg, South AfricaAIDS Behav20172161632164010.1007/s10461-016-1442-627251436 36.TaoJet al.Impact of" exact="depression" post="and anxiety on initiation of antiretroviral therapy among men"/>
 <result pre="in Johannesburg, South AfricaAIDS Behav20172161632164010.1007/s10461-016-1442-627251436 36.TaoJet al.Impact of depression and" exact="anxiety" post="on initiation of antiretroviral therapy among men who have"/>
 <result pre="men who have sex with men with newly diagnosed HIV" exact="infections" post="in ChinaAIDS Patient Care STDs20173129610410.1089/apc.2016.021428170305 37.GoodnessTMet al.Depressive symptoms and"/>
 <result pre="37.GoodnessTMet al.Depressive symptoms and antiretroviral therapy (ART) initiation among HIV-infected" exact="Russian" post="drinkersAIDS Behav20141861085109310.1007/s10461-013-0674-y24337725 38.Parruti G, Manzoli L, Toro PM, et"/>
 <result pre="Patient Care STDs2006201485610.1089/apc.2006.20.4816426156 40.UstinovAet al.Psychiatric distress, drug use, and HIV" exact="viral" post="load suppression in RussiaAIDS Behav20162081603160810.1007/s10461-016-1297-x26809193 41.FeldmanMBet al.Crystal methamphetamine use"/>
 <result pre="New YorkDrug Alcohol Depend201514726627110.1016/j.drugalcdep.2014.09.78025482501 42.Goodman-MezaDet al.Methamphetamine use drives decreases in" exact="viral" post="suppression for people living with HIV released from a"/>
 <result pre="Behav201136776276310.1016/j.addbeh.2011.02.00121396784 45.AibibulaWet al.Association between depressive symptoms, CD4 count and HIV" exact="viral" post="suppression among HIV-HCV co-infected peopleAIDS Care201830564364910.1080/09540121.2018.143138529374972 46.CastelADet al.Disparities in"/>
 <result pre="HIV-HCV co-infected peopleAIDS Care201830564364910.1080/09540121.2018.143138529374972 46.CastelADet al.Disparities in achieving and sustaining" exact="viral" post="suppression among a large cohort of HIV-infected persons in"/>
</results>
